Dr Jun Yan and her team are interested in a molecular pathway called the NF-kB pathway that is present in cells throughout the body and controls many basic functions of cells. However, the NF-kB pathway doesn’t operate in the same way in all types of cells. In immune cells, activating the NF-kB pathway causes inflammation. In contrast, in brain cells, activating the NF-kB pathway appears to be beneficial, allowing the formation of new memories as well as protecting nerve cells from damage.
Dr Yan’s team have previously found that people with MS have a lower-than-normal level of a molecule, called IkB-a, that blocks the NF-kB pathway. This means that immune cells in people with MS tend to be more activated and inflammatory than those in other people.
Currently, there is nothing known about how the lower-than-normal levels of IkB-a seen in people with MS might affect the cells in the brain. A complicating factor in studying this is that we cannot study pieces of people’s brains to look at the effects of low levels of IkB-a. Therefore, we will explore whether we can use a type of stem cell called an induced pluripotent stem cell (iPSC) to produce brain cells and brain organoids (mini brains in a dish) that can be used to look at the effects of low levels of IkB-a in brain cells.
In this study, Dr Jun Yan and her team achieved three key outcomes. Firstly, they successfully derived important brain cells; neurons and astrocytes from human-induced pluripotent stem cells (iPSCs) and prepared brain organoids for a period of up to 12 weeks in a laboratory setting. Secondly, they were able to effectively reduce the levels of IkB-a in iPSC-derived brain cells. Lastly, they conducted investigations into the level of NF-kB in brain organoids at different stages of development. Â
These outcomes demonstrate significant progress in the development of a model system using iPSC-derived brain cells and organoids to explore the effects of IkB-a levels on brain cells and NF-kB expression. The team are now finalising their findings for publication.
Updated 31 March 2023
$25,000
2021
2 years
Current project